03/04/2024 |
PharmaLundensis AB |
Tord Staffan Håkan Skogvall |
Chief Executive Officer (CEO)/Managing Directory |
|
Subscription |
Phal |
Share |
SE0019912783 |
28/03/2024 |
200,000 |
Quantity |
0.90 |
SEK |
|
Notification
|
20/03/2024 |
PharmaLundensis AB |
Tord Staffan Håkan Skogvall |
Chief Executive Officer (CEO)/Managing Directory |
|
Acquisition |
Phal |
Share |
SE0019912783 |
18/03/2024 |
95,000 |
Quantity |
0.85 |
SEK |
|
Notification
|
14/03/2024 |
PharmaLundensis AB |
Tord Staffan Håkan Skogvall |
Chief Executive Officer (CEO)/Managing Directory |
|
Acquisition |
Phal |
Share |
SE0019912783 |
12/03/2024 |
46,270 |
Quantity |
0.83 |
SEK |
|
Notification
|
12/03/2024 |
PharmaLundensis AB |
Tord Staffan Håkan Skogvall |
Chief Executive Officer (CEO)/Managing Directory |
|
Acquisition |
Phal |
Share |
SE0019912783 |
08/03/2024 |
82,486 |
Quantity |
0.64 |
SEK |
|
Notification
|
21/02/2024 |
PharmaLundensis AB |
Tord Staffan Håkan Skogvall |
Chief Executive Officer (CEO)/Managing Directory |
|
Acquisition |
Phal |
Share |
SE0019912783 |
19/02/2024 |
201,850 |
Quantity |
0.653 |
SEK |
|
Notification
|
29/12/2023 |
PharmaLundensis AB |
Tord Staffan Håkan Skogvall |
Chief Executive Officer (CEO)/Managing Directory |
|
Acquisition |
Phal Aktie |
Share |
SE0019912783 |
27/12/2023 |
129,790 |
Quantity |
0.36 |
SEK |
|
Notification
|
02/07/2023 |
PharmaLundensis AB |
Tord Staffan Håkan Skogvall |
Chief Executive Officer (CEO)/Managing Directory |
|
Acquisition |
Phal |
Share |
SE0019912783 |
30/06/2023 |
273,813 |
Quantity |
0.31 |
SEK |
|
Notification
|
27/03/2023 |
PharmaLundensis AB |
Tord Staffan Håkan Skogvall |
Chief Executive Officer (CEO)/Managing Directory |
|
Subscription |
Phal BTU |
BTU |
SE0019912783 |
24/03/2023 |
1,064,343 |
Quantity |
0.50 |
SEK |
History |
Notification
|
27/03/2023 |
PharmaLundensis AB |
Tord Staffan Håkan Skogvall |
Chief Executive Officer (CEO)/Managing Directory |
|
Acquisition |
Phal BTU |
BTU |
SE0019912783 |
24/03/2023 |
1,064,343 |
Quantity |
0.50 |
SEK |
Revised |
Notification
|
13/03/2023 |
PharmaLundensis AB |
Tord Staffan Håkan Skogvall |
Chief Executive Officer (CEO)/Managing Directory |
|
Acquisition |
PharmaLundensis |
Share |
SE0003359710 |
13/03/2023 |
187,984 |
Quantity |
0.51 |
SEK |
|
Notification
|